The Future of Molecular Testing Has Arrived.

Complete, easy-to-use testing at the Point of Need™ with full results delivered directly to your smartphone in under one hour.

Learn more about our products

Partner with us

The Alveo platform brings molecular detection out of the lab and into the field.

Handheld & Portable

Accurate, Rapid Results

Multiplex Capable

Simple & Easy to Use

Affordable & Accessible

Cloud-Connected & Secure

Access to actionable, early detection is key to managing global health, food security, and supply chain resiliency.

The problem

In the United States alone, the recent outbreak of Highly Pathogenic Avian Influenza (HPAI) has affected over 90 million birds thus far.¹

To prevent further spread, we must work across sectors to better prepare and respond to outbreaks.

¹ APHIS, Confirmations of Highly Pathogenic Avian Influenza in Commercial and Backyard Flocks, 2024.

The problem

Globally, we lose 17-30% of the five major food crops each year to plant pathogens².

With the planet poised to add another 2 billion people, we must find creative ways to increase crop yields and reduce food insecurity.

² Molecular Approaches for Low-Cost Point-of Care Pathogen Detection in Agriculture and Forestry, 2020.

The problem

In 2020, The Institute for Supply Management found that nearly 75% of companies reported supply chain disruptions due to COVID-19³.

Expanding healthcare provider access to rapid molecular detection is critical to global health in today’s interconnected world.

³ISM. COVID-19's Global Impact on Supply Chains. Updated, 2021.

OUR SOLUTION

Get to know the Alveo Platform

Harnessing the power of molecular detection in our handheld analyzer, Alveo enables rapid, actionable pathogen detection in a growing number of fields precisely when — and where — it matters most.

Research & Development

Plant, Crop, and Soil

Cartridge

Each cartridge is preloaded with a QR code for secure, automated test registration and result tracking.

Analyzer

Our analyzer delivers high-sensitivity molecular results in under an hour—engineered for use at the Point of Need™.

Smartphone

The Alveo Sense™ app guides the workflow and delivers secure, real-time results to your smartphone.

Filtration Syringe

The filtration syringe enables clean, consistent sample processing for complex sample types.

ISO certified for the design, development, and manufacture of in vitro diagnostic kits and analyzers for the detection of infectious disease

CE Marked for use in the in vitro diagnostic (IVD) molecular testing market.

Uniting Expertise to Redefine Poultry Health Diagnostics

We have joined forces with Netherlands-based Royal GD to deliver transformative solutions for farm animal health and welfare. By combining Alveo’s groundbreaking molecular testing platform with Royal GD’s unmatched veterinary expertise, this collaboration represents a powerful step forward in enabling fast, accurate, and accessible diagnostics at the point of need.

Learn More About Royal GD

Fostering partnerships that create access to rapid, early detection across sectors and pathogen types.

Partner with Alveo

The Future of Molecular Testing Has Arrived.

The Alveo platform brings molecular detection out of the lab and into the field.

Access to actionable, early detection is key to managing global health, food security, and supply chain resiliency.

There have been over a thousand recorded Avian Flu outbreaks since 2016. And for every million birds lost, there is also a 1.6% price increase².

Three out of four new or emerging infectious diseases in people come from animals¹.

By 2050, we will need to feed a global population of 10 billion people³.

Currently, we lose up to a third of food crops to pathogens⁴.

In the United States alone, the recent outbreak of Highly Pathogenic Avian Influenza (HPAI) has affected over 90 million birds thus far.¹

Globally, we lose 17-30% of the five major food crops each year to plant pathogens².

In 2020, The Institute for Supply Management found that nearly 75% of companies reported supply chain disruptions due to COVID-19³.

Get to know the Alveo Platform

Anywhere, anytime analyzer

Simple, seamless workflow

Direct Electrical Sensing

Open platform technology

Uniting Expertise to Redefine Poultry Health Diagnostics

Fostering partnerships that create access to rapid, early detection across sectors and pathogen types.

Dr. Rothman is a distinguished biochemist and cell biologist whose work led to understand

Dr. Rothman is a distinguished biochemist and cell biologist whose work led to understand

Their first co-developed product, an Avian Influenza test was introduced in 2024

Their first co-developed product, an Avian Influenza test was introduced in 2024

Alveo Partnerships are Driving Innovation and Impact.

Alveo Partnerships are Driving Innovation and Impact.

The Alveo platform brings molecular detection out of the lab and into the field.

Access to actionable, early detection is key to managing global health, food security, and supply chain resiliency.

There have been over a thousand recorded Avian Flu outbreaks since 2016. And for every million birds lost, there is also a 1.6% price increase2.

Three out of four new or emerging infectious diseases in people come from animals1.

By 2050, we will need to feed a global population of 10 billion people3.

Currently, we lose up to a third of food crops to pathogens4.

In the United States alone, the recent outbreak of Highly Pathogenic Avian Influenza (HPAI) has affected over 90 million birds thus far.1

Globally, we lose 17-30% of the five major food crops each year to plant pathogens2.

In 2020, The Institute for Supply Management found that nearly 75% of companies reported supply chain disruptions due to COVID-193.

Get to know the Alveo Platform

Anywhere, anytime analyzer

Simple, seamless workflow

Direct Electrical Sensing

Open platform technology

Uniting Expertise to Redefine Poultry Health Diagnostics

Fostering partnerships that create access to rapid, early detection across sectors and pathogen types.

Dr. Rothman is a distinguished biochemist and cell biologist whose work led to understand

Dr. Rothman is a distinguished biochemist and cell biologist whose work led to understand

Their first co-developed product, an Avian Influenza test was introduced in 2024

Their first co-developed product, an Avian Influenza test was introduced in 2024

Alveo Partnerships are Driving Innovation and Impact.

Alveo Partnerships are Driving Innovation and Impact.

There have been over a thousand recorded Avian Flu outbreaks since 2016. And for every million birds lost, there is also a 1.6% price increase².

Three out of four new or emerging infectious diseases in people come from animals¹.

By 2050, we will need to feed a global population of 10 billion people³.

Currently, we lose up to a third of food crops to pathogens⁴.

In the United States alone, the recent outbreak of Highly Pathogenic Avian Influenza (HPAI) has affected over 90 million birds thus far.¹

Globally, we lose 17-30% of the five major food crops each year to plant pathogens².

In 2020, The Institute for Supply Management found that nearly 75% of companies reported supply chain disruptions due to COVID-19³.